StandardAero, Inc. SARO 深 沪
等待开盘 10-04 09:30:00 美东时间
26.60
-0.740
-2.71%
华盛通- 最 高27.38
- 今 开27.38
- 成交量 125.15万股
- 最 低 26.56
- 昨 收 27.34
- 总市值 88.84亿
- 52周最高 33.00
- 市盈率 静 701.85
- 换手率 0.37%
- 52周最低 21.31
- 委 比 0.00%
- 总股本 3.34亿
- 历史最高 34.38
- 量 比 0.42
- 振 幅 3.00%
- 历史最低 21.31
- 每 手 1
- 风险率 2.14%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多StandardAero Appoints New President for Component Repair
StandardAero, Inc. ( ($SARO) ) just unveiled an announcement. StandardAero, Inc...
09-23 04:36
美股大行评级 | Tigress Financial：维持苹果"强烈买入"评级，目标价升至305美元；杰富瑞维持百度"买入"评级，目标价升至157美元
今日重点评级关注：HC Wainwright & Co.：维持Astria Therapeutics"买入"评级，目标价从16美元升至20美元；HC Wainwright & Co.：维持Avalo Therapeutics"买入"评级，目标价从15美元升至25美元
09-18 10:13
美股大行评级 | 潜在涨幅280.95%！HC Wainwright & Co.上调Immix Biopharma目标价至8美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从7美元升至8美元；Maxim Group：上调CNS Pharma评级至"买入"，目标价20美元
09-15 11:13
Barclays Initiates Coverage On StandardAero with Overweight Rating, Announces Price Target of $32
Barclays analyst David Strauss initiates coverage on StandardAero (NYSE:SARO) with a Overweight rating and announces Price Target of $32.
09-12 19:08
StandardAero, Inc. (SARO) Receives a Buy from J.P. Morgan
In a report released on August 14, Seth Seifman from J.P. Morgan maintained a B...
08-16 20:07
StandardAero上调2025年营收预期至60.25亿美元
StandardAero（SARO）下跌4.5%。该公司将2025年营收预期上调至60.25亿美元，主要基于商业航空和公务航空领域的强劲需求。该公司正在扩大...
08-14 22:44
StandardAero shares are trading lower after the company reported worse-than-expected Q2 EPS results.
StandardAero shares are trading lower after the company reported worse-than-exp...
08-14 20:11
StandardAero Raises FY2025 Sales Guidance from $5.825B-$5.975B to $5.875B-$6.025B vs $5.937B Est
StandardAero (NYSE:SARO) raises FY2025 sales outlook from $5.825 billion-$5.975 billion to $5.875 billion-$6.025 billion vs $5.937 billion estimate.
08-14 04:19
StandardAero Q2 EPS $0.20 Misses $0.21 Estimate, Sales $1.529B Beat $1.495B Estimate
StandardAero (NYSE:SARO) reported quarterly earnings of $0.20 per share which missed the analyst consensus estimate of $0.21 by 4.76 percent. This is a 900 percent increase over earnings of $0.02 per share from the same
08-14 04:16
